share_log

药康生物(688046.SH):股东青岛国药累计减持1.0880%股份

Yao Kang Biological (688046.SH): Shareholder Qingdao National Medicine accumulatively reduced its shareholding by 1.0880%.

Gelonghui Finance ·  Jul 31 06:21

On July 31st, Gelunhui reported that PharmaKang Biological (688046.SH) received the Notification Letter of Shareholding Reduction from Qingdao National Pharmaceutical, a shareholder who owns more than 5% of the shares, on July 31st, 2024. Between October 31st, 2023 and July 31st, 2024, Qingdao National Pharmaceutical reduced its total shareholding in the company by 4.4608 million shares, or 1.0880% of the total share capital of the company, through block trading and centralized bidding.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment